Skip to content

Cash ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.4×-0.3×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.3×0.0×
IAR
Integra LifeSciencesIART
0.7×+0.4×
ITG
Integer HoldingsITGR
-0.1×
Glaukos logo
GlaukosGKOS
1.2×-0.5×
HRO
HarrowHROW
+0.7×

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+77.9%
Enterprise value$1.35B+100.0%
P/S+2.1×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

Based on the most recent quarter.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's cash ratio?
Staar Surgical (STAA) reported cash ratio of 2.2× in Q1 2026.
How has Staar Surgical's cash ratio changed year-over-year?
Staar Surgical's cash ratio decreased by 14.6% year-over-year, from 2.5× to 2.2×.
What is the long-term trend for Staar Surgical's cash ratio?
Over 5 years (2020 to 2025), Staar Surgical's cash ratio has grown at a -9.6% compound annual growth rate (CAGR), from 3.7× to 2.2×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.